Edwards Lifesciences (EW) Shares Outstanding (2009 - 2026)
Edwards Lifesciences (EW) posted quarterly Shares Outstanding (Entity) of $660.0 million for Q1 2026, up 0.63% year-over-year from $655.9 million in Q1 2025, and little changed quarter-over-quarter from $658.7 million in Q4 2025.
Edwards Lifesciences (EW) Shares Outstanding (2009 - 2026) Analysis & Trends
Edwards Lifesciences' Shares Outstanding (Entity) history runs 18 years deep, the most recent figure standing at $660.0 million for Q1 2026.
- In Q1 2026, Shares Outstanding (Entity) rose 0.63% year-over-year to $660.0 million; the TTM figure through Mar 2026 stood at $660.0 million (up 0.63% YoY), while the FY2025 annual figure was $658.7 million, up 0.6% from the prior year.
- Shares Outstanding (Entity) for Q1 2026 stood at $660.0 million, roughly flat from $658.7 million in the prior quarter.
- The five-year high for Shares Outstanding (Entity) was $660.0 million in Q1 2026, with the low at $642.9 million in Q1 2022.
- The 5-year median for Shares Outstanding (Entity) is $651.8 million (2024), against an average of $651.8 million.
- The sharpest annual moves came in 2022 and 2025: Shares Outstanding (Entity) climbed 0.85% in 2022, then climbed 0.6% in 2025.
- Edwards Lifesciences' Shares Outstanding (Entity) stood at $646.3 million in 2022, then gained by 0.65% to $650.5 million in 2023, then increased by 0.66% to $654.8 million in 2024, then climbed by 0.6% to $658.7 million in 2025, then gained by 0.2% to $660.0 million in 2026.
- Business Quant data shows EW's Shares Outstanding (Entity) at $660.0 million in Q1 2026, $658.7 million in Q4 2025, and $658.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 1.74 Bn |
| 2 | Stryker | 130.69 Bn | 127.22 Bn | 4.50 Bn | 383.50 Mn |
| 3 | Medtronic | 120.89 Bn | 111.67 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 75.26 Bn | 74.72 Bn | 3.85 Bn | 1.47 Bn |
| 5 | Edwards Lifesciences | 52.88 Bn | 48.63 Bn | 1.35 Bn | 576.40 Mn |
| 6 | Dexcom | 34.76 Bn | 32.81 Bn | 830.00 Mn | 382.20 Mn |
| 7 | GE HealthCare Technologies | 33.84 Bn | 31.74 Bn | 2.18 Bn | 453.00 Mn |
| 8 | Koninklijke Philips | 26.47 Bn | 23.15 Bn | 4.55 Bn | 955.57 Mn |
| 9 | Steris | 23.26 Bn | 22.78 Bn | 684.20 Mn | 97.60 Mn |
| 10 | Zimmer Biomet Holdings | 19.46 Bn | 19.05 Bn | 1.54 Bn | 192.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 576.40 Mn |
| Mar 31, 2026 | 579.20 Mn |
| Dec 31, 2025 | 584.80 Mn |
| Sep 30, 2025 | 584.70 Mn |
| Jun 30, 2025 | 587.00 Mn |
| Mar 31, 2025 | 586.90 Mn |
| Dec 31, 2024 | 597.70 Mn |
| Sep 30, 2024 | 597.20 Mn |
| Jun 30, 2024 | 602.10 Mn |
| Mar 31, 2024 | 601.60 Mn |
| Dec 31, 2023 | 606.70 Mn |
| Sep 30, 2023 | 607.00 Mn |
| Jun 30, 2023 | 606.90 Mn |
| Mar 31, 2023 | 607.50 Mn |
| Dec 31, 2022 | 619.00 Mn |
| Sep 30, 2022 | 619.80 Mn |
| Jun 30, 2022 | 620.90 Mn |
| Mar 31, 2022 | 622.10 Mn |
| Dec 31, 2021 | 623.30 Mn |
| Sep 30, 2021 | 623.60 Mn |